Quantum BioPharma director Lakshmi P. Kotra resigns, stays on as senior clinical adviser
PUBT · 2d ago
Share
Listen to the news
- Quantum BioPharma director Lakshmi P. Kotra resigned from the board and all roles across the company and its subsidiaries, effective June 1, 2026.
- Kotra cited other personal and professional commitments.
- He will remain with the company as a senior clinical advisor.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief on June 01, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending